Role and clinicopathological significance of platelets on tumor angiogenesis
Role and clinicopathological significance of platelets on tumor angiogenesis
批准号:
13671341
负责人:
AIURA Koichi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
当癌细胞与血小板共孵育时,癌细胞产生的IL-8比没有血小板孵育的癌细胞产生的IL-8增加。白细胞介素-8 mRNA在癌细胞中的表达也因血小板的存在而增强。在化学侵袭实验中,血小板促进胰腺癌细胞的侵袭性。Geratin Zymography和Western blot分析显示,血小板显著增强了癌细胞的MMP-9。这些对MMP-9产生的促进作用被抗血小板药物的加入所抑制。此外,通过三维培养和成管实验评估血小板对肿瘤血管生成的影响。与单独培养癌细胞的上清相比,与癌细胞和血小板共培养的上清可促进HUVEC的管状形成。当血小板和癌细胞共孵育时,VEGF的产生协同增加。这些发现表明,血小板促进肿瘤血管生成和侵袭性,部分是通过促进癌细胞血管生成因子和金属蛋白酶的产生。
英文摘要
When cancer cells were co-incubated with platelets, IL-8 production by cancer cells was increased compared with IL-8 production by cancer cells incubated without platelets. The expression of IL-8 mRNA by cancer cells was also found to be enhanced by the existence of platelets from Northern blot analysis. Platelets promoted the invasiveness of pancreatic cancer cells in the chemoinvasion assay. Geratin Zymography and Western blot analysis revealed that MMP-9 from cancer cells was significantly enhanced by platelets. These promotive effects on MMP-9 production were inhibited by the addition of anti-platelet agents. Furthermore, the effects of platelets on tumor angiogenesis were evaluated by 3D cultivation and tube formation assay. Tube formation of HUVEC was promoted by the supernatant from co-culture with cancer cells and platelets, compared with the supernatant from cancer cells alone. The production of VEGF was synergistically increased when platelets and cancer cells were co-incubated. These findings suggest that platelets enhanced tumor angiogenesis and invasiveness, partly, by enhancement of cancer cells on the production of both angiogenic factors and metalloprotease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of the synergistic anti-proliferation effects of heparin or NF-κB inhibitor and gemcitabine on pancreatic cancer
-
批准号:21591782
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:AIURA Koichi
-
依托单位:
The development of new therapy for digestive organ solid cancer using fibroblasts genetically engineered to produce cytokine combined with anti-platelet agents
-
批准号:15591359
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:AIURA Koichi
-
依托单位:
Pathophysiological significance of platelets on cancer invasion, proliferation, and angiogenesis
-
批准号:11671181
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:AIURA Koichi
-
依托单位:
Identification of new oncogenes related to human cancer by human genomic DNA analysis based on two-dimensio electrophoresi
-
批准号:09671249
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:AIURA Koichi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
-
批准号:32070790
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:徐小燕
-
依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
-
批准号:81171370
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:朱朝晖
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
99mTc-3PRGD2 SPECT显像用于评价肺癌抗新生血管药物疗效的动物研究及肺癌诊断临床研究
-
批准号:81171369
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:李方
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位: